Alembic Pharma gets US FDA nod for anticoagulant Dabigatran

Alembic Pharmaceuticals said that it has received final approval from the US Food & Drug Administration (US FDA) for its abbreviated new drug application (ANDA) Dabigatran Etexilate Capsules.

By: business-standard.com

Aug 13 2024
0
0 Views

Alembic Pharma gets US FDA nod for anticoagulant Dabigatran

Intellect launches AI platform 'Purple Fabric' for financial institutions

Hindustan Copper shares jump 6% after profits grow two-fold in Q1 earnings

Sensex slides 335 pts; European mkt opens higher

Syncom Formulations gains after Q1 PAT rises over 73% YoY

Alembic Pharma gets US FDA nod for anticoagulant Dabigatran

Bentley Commercial Enterprises reports standalone net loss of Rs 0.06 crore in the June 2024 quarter

Terraform Realstate reports standalone net loss of Rs 0.01 crore in the June 2024 quarter

ADC India Communications reports standalone net profit of Rs 6.96 crore in the June 2024 quarter

Kunststoffe Industries standalone net profit rises 57.14% in the June 2024 quarter

Consolidated Finvest & Holdings standalone net profit rises 122.05% in the June 2024 quarter

Anupam Finserv standalone net profit rises 33.33% in the June 2024 quarter

United Credit standalone net profit rises 18.18% in the June 2024 quarter

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

Get Reliable Matka Guessing Forum with our Satta Matka Expert and Get all Matka Chart For Free.

Alembic Pharma gets US FDA nod for anticoagulant Dabigatran

Related